MOLDTKPAC NSE filing

Mold-Tek Packaging Q3 FY26 Revenue Up 4% to ₹198.43 Cr, PAT Rises 5% to ₹14.35 Cr

The RealCase readMedium impact Positive

Mold-Tek Packaging reported Q3 FY26 revenue of ₹198.43 Cr, up 4% YoY, with PAT at ₹14.35 Cr, up 5%. For 9MFY26, revenue increased 12% to ₹648.75 Cr and PAT grew 18% to ₹52.23 Cr. The company signed an MoU with Vibe Generation Holdings (UK) for caps and closures, targeting USD 25-30 Mn revenue over 5 years. Pharma sales surged 190% in Q3.

Why it matters

The financial results show steady growth, and the strategic partnership indicates future expansion. However, the immediate impact on the stock price might be moderate as the full benefits of the MoU are yet to be realized.

The market read

The company reported growth in revenue, EBITDA, and PAT for both the quarter and nine-month periods. The strategic MoU with a UK-based company also presents a significant future growth opportunity.

Mold-Tek Packaging Limited has announced its financial results for the quarter and nine months ended December 31, 2025. The company reported a total revenue of ₹198.43 crore for Q3 FY26, marking a 4% increase from ₹190.68 crore in the same period last year. The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) grew by 14% to ₹38.67 crore, compared to ₹33.98 crore in Q3 FY25. Profit After Tax (PAT) saw a 5% rise, reaching ₹14.35 crore from ₹13.64 crore in the prior year's quarter.

For the nine months ended December 31, 2025 (9MFY26), the company's total revenue stood at ₹648.75 crore, an increase of 12% from ₹578.71 crore in 9MFY25. EBITDA for the nine-month period grew by 20% to ₹125.55 crore from ₹104.78 crore, while PAT increased by 18% to ₹52.23 crore from ₹44.28 crore.

Sales volume for Q3 FY26 was 9,807 MT, a 6% increase from 9,255 MT in Q3 FY25. The Pharma vertical demonstrated significant growth, with sales increasing by 190% year-on-year to ₹10.81 crore in Q3 FY26. The company also highlighted a strategic Memorandum of Understanding (MoU) with Vibe Generation Holdings (UK) for high-precision caps and closures, targeting a global market opportunity of approximately USD 1 billion and a revenue potential of USD 25-30 million over five years.

The investor presentation also detailed segment-wise revenue performance, with Paints contributing ₹90 crore, Lubes ₹34 crore, Food ₹36 crore, Q Pack ₹32 crore, and Pharma ₹10.81 crore in Q3 FY26. The company emphasized its strong market presence, innovation in packaging solutions like In-Mould Labelling (IML), and backward integration as key competitive advantages.

Filing to action

What to do with a filing like this

Mold-Tek Packaging Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Mold-Tek Packaging Limited. Read the original for the full detail.

View original filing